Hosted on MSN
Long-term pharmacological treatment shows promise against memory impairments in Down syndrome
In 2019, a research group led by Andrés Ozaita, of the Department of Medicine and Life Sciences at Pompeu Fabra University, described that mice models for Down syndrome have more cannabinoid receptor ...
Detail of the hippocampus of control subjects (left) and with Down syndrome (right) where the CBR1 receptor is observed in brown and the nuclei of neurons in lilac. In 2019, a research group led by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results